- Home
- FMS vs BCH Comparison
FMS vs BCH Comparison
Compare FMS & BCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- BCH
- Stock Information
- Founded
- FMS 1996
- BCH 1893
- Country
- FMS Germany
- BCH Chile
- Employees
- FMS N/A
- BCH N/A
- Industry
- FMS Misc Health and Biotechnology Services
- BCH Commercial Banks
- Sector
- FMS Health Care
- BCH Finance
- Exchange
- FMS Nasdaq
- BCH Nasdaq
- Market Cap
- FMS 15.0B
- BCH 15.0B
- IPO Year
- FMS 1996
- BCH 2002
- Fundamental
- Price
- FMS $27.16
- BCH $32.72
- Analyst Decision
- FMS Sell
- BCH Hold
- Analyst Count
- FMS 2
- BCH 2
- Target Price
- FMS $30.00
- BCH $28.00
- AVG Volume (30 Days)
- FMS 292.2K
- BCH 376.0K
- Earning Date
- FMS 11-04-2025
- BCH 10-30-2025
- Dividend Yield
- FMS 2.10%
- BCH 4.82%
- EPS Growth
- FMS 23.39
- BCH N/A
- EPS
- FMS 2.62
- BCH 0.01
- Revenue
- FMS $22,922,038,756.00
- BCH $2,793,481,720.00
- Revenue This Year
- FMS $1.83
- BCH $18.25
- Revenue Next Year
- FMS $3.27
- BCH $5.09
- P/E Ratio
- FMS $20.35
- BCH $13.00
- Revenue Growth
- FMS 0.53
- BCH N/A
- 52 Week Low
- FMS $18.94
- BCH $22.06
- 52 Week High
- FMS $30.46
- BCH $33.28
- Technical
- Relative Strength Index (RSI)
- FMS 60.34
- BCH 68.68
- Support Level
- FMS $26.49
- BCH $30.64
- Resistance Level
- FMS $27.54
- BCH $33.28
- Average True Range (ATR)
- FMS 0.39
- BCH 0.62
- MACD
- FMS 0.02
- BCH 0.20
- Stochastic Oscillator
- FMS 72.73
- BCH 84.31
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
About BCH Banco De Chile ADS
Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.